Engineering high-affinity PD-1 variants for optimized immunotherapy and immuno-PET imaging | PNAS
Anti-Mouse CD279 Clone 29F.1A12 (PD-1) - In vivo Functional Grade
Anti-PD-1 Neutralizing Antibody
Release the B7.1! Anti-PD-L1 breaks PD-L1's grip
Characterization of the Anti–PD-1 Antibody REGN2810 and Its Antitumor Activity in Human PD-1 Knock-In Mice | Molecular Cancer Therapeutics
Anti-PD-1 Blocking Antibody Inhibits Human Melanoma Xenograft Growth in... | Download Scientific Diagram
Anti-PD-1 Antibody Therapy Potently Enhances the Eradication of Established Tumors By Gene-Modified T Cells | Clinical Cancer Research
Anti-PD-L1 mIgG1e3 monoclonal antibody | Atezolizumab-based
Anti-PD-1 antibody decreases tumour-infiltrating regulatory T cells | BMC Cancer | Full Text
Human PD-1 Antibody (PD1.D3), mAb, Mouse - GenScript
TLR4 signaling improves PD-1 blockade therapy during chronic viral infection
PD-L1 on dendritic cells attenuates T cell activation and regulates response to immune checkpoint blockade | Nature Communications
A human programmed death-ligand 1-expressing mouse tumor model for evaluating the therapeutic efficacy of anti-human PD-L1 antibodies | Scientific Reports
Bio X Cell - InVivoPlus anti-mouse PD-1 (CD279)
Bio X Cell - PD1 Antibodies
A. C57BL/6 mice were intraperitoneally treated with an anti-PD-1... | Download Scientific Diagram
Anti-mouse PD-1 (CD279) Antibody | Recombinant RMP1-14 | InvivoGen
Anti-PD-1 Blocking Antibody Inhibits Murine Melanoma Growth in... | Download Scientific Diagram
PD-L1 (D5V3B) Rabbit mAb (Mouse Specific; IHC Specific) | Cell Signaling Technology
Anti-PD-1 Antibody Therapy Potently Enhances the Eradication of Established Tumors By Gene-Modified T Cells | Clinical Cancer Research
Combined immunotherapy with anti-PDL-1/PD-1 and anti-CD4 antibodies cures syngeneic disseminated neuroblastoma | Scientific Reports
Anti-mouse PD-1 (CD279) Antibody | Recombinant RMP1-14 | InvivoGen
Bio X Cell - InVivoMAb anti-mouse PD-1 (CD279)
Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo | Nature Biotechnology
Human PD-L1 Antibody (PDL1.D1), mAb, Mouse - GenScript
Mouse PD-1 Antibody AF1021: R&D Systems
Selective HDAC6 inhibitors improve anti-PD-1 immune checkpoint blockade therapy by decreasing the anti-inflammatory phenotype of macrophages and down-regulation of immunosuppressive proteins in tumor cells | Scientific Reports
